Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Energy metabolism via glucose utilization refers to the cellular and systemic processes by which glucose, a simple sugar, is used as the primary fuel for energy production in most mammalian tissues. Glucose is central to energy consumption: carbohydrates and proteins are ultimately broken down into glucose, which serves as the main metabolic fuel for mammals and is especially critical for organs with high energy demands such as the brain. The process encompasses several interconnected biochemical pathways that convert glucose into usable chemical energy (ATP), storage forms (glycogen), or biosynthetic precursors.
Varies depending on the specific drug; examples include: - Insulin: promotes glucose uptake and utilization - Metformin: reduces hepatic glucose production and increases insulin sensitivity - Thiazolidinediones: increase insulin sensitivity - Sulfonylureas: stimulate insulin secretion - SGLT2 inhibitors: reduce glucose reabsorption in the kidney
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Energy Metabolism via Glucose Utilization.